Showing results (261-270 of 313) with videos related to

Sort By:
Pageof 32
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|September 29, 2021
Malnutrition modifies the response to multimodal prehabilitation: a pooled analysis of prehabilitation trialsC Gillis, T R Fenton, L Gramlich, et al.
Case Reports in Gastroenterology|July 24, 2010
Giant Sigmoid Diverticulum: A Rare Presentation of a Common PathologyA Guarnieri, M Cesaretti, A Tirone, et al.
Alzheimer Disease and Associated Disorders|January 1, 1992
Alzheimer disease brain extract stimulates branching of laminin-mediated neuronal processesS D Kittur, H Endo, W H Adler, et al.
Journal of Neuroscience Research|September 1, 1995
Neurotoxicity of the human immunodeficiency virus type 1 tat transactivator to PC12 cells requires the Tat amino acid 49-58 basic domainB S Weeks, D M Lieberman, B Johnson, et al.
Biochemical and Biophysical Research Communications|July 15, 1994
Lymphocytes and promonocytes attach to the synthetic [Tyr5,12, Lys7]- polyphemusin II peptideB S Weeks, M Nomizu, A Otaka, et al.
HIV Clinical Trials|August 9, 2013
Randomized trial to evaluate cardiometabolic and endothelial function in patients with plasma HIV-1 RNA suppression switching to darunavir/ritonavir with or without nucleoside analoguesG Guaraldi, S Zona, A Cossarizza, et al.
Cell Death and Differentiation|October 14, 2003
Mutational analysis of the interacting cell death regulators CED-9 and CED-4S Ottilie, Y Wang, S Banks, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 1995
Reproduction and sera embryotoxicity after immunization of monkeys with the laminin peptides YIGSR, RGD, and IKVAVB J Chambers, N W Klein, S H Conrad, et al.
The Journal of Cell Biology|August 1, 1991
HIV-1 infection of human T lymphocytes results in enhanced alpha 5 beta 1 integrin expressionB S Weeks, M E Klotman, S Dhawan, et al.
Gynecologic Oncology|November 15, 2021
Gynecologic oncologist impact on adjuvant chemotherapy care for stage II-IV ovarian cancer patientsKristin S Weeks, Charles F Lynch, Michele West, et al.
Pageof 32